Live from the NIH registry
Studies recruiting near Nampa right now
Top 25 of 261 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
St. Alphonsus Regional Medical Center — Boise, Idaho (18.1 mi)
· Sponsor: GT Medical Technologies, Inc.
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 300 participants sought
Velocity Clinical Research - Boise — Meridian, Idaho (8.8 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Boise, Idaho (18.1 mi)
· Sponsor: Sameek Roychowdhury
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Treasure Valley Medical Research — Boise, Idaho (18.1 mi)
· Sponsor: Eli Lilly and Company
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
Phase 3
Interventional 252 participants sought
High Desert Heart & Vascular — Meridian, Idaho (8.8 mi)
· Sponsor: Eli Lilly and Company
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Boise, Idaho Investigative Site 10073 — Boise, Idaho (18.1 mi)
· Sponsor: Colorado Prevention Center
Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy
TBI Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder
Phase 2
Interventional 54 participants sought
Summit Hyperbarics and Wellness — Boise, Idaho (18.1 mi)
· Sponsor: Summit Hyperbarics and Wellness
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Paradigm Clinical Research - Boise, ID — Boise, Idaho (18.1 mi)
· Sponsor: Sparrow Pharmaceuticals
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Treasure Valley Medical Research — Boise, Idaho (18.1 mi)
· Sponsor: Ardelyx
HBOT Effects on First Responders' Cognition and Well-Being
Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder
Phase 2
Interventional 54 participants sought
Summit Hyperbarics and Wellness — Boise, Idaho (18.1 mi)
· Sponsor: Summit Hyperbarics and Wellness
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (18.1 mi)
· Sponsor: Children's Oncology Group
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Saint Luke's Cancer Institute - Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: NRG Oncology
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Acute Respiratory Distress Syndrome, ARDS
Phase 3
Interventional 970 participants sought
Direct Biologics Investigational Site — Boise, Idaho (18.1 mi)
· Sponsor: Direct Biologics, LLC
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity, Overweight
Phase 3
Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Meridian, Idaho (8.8 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Boise VA Medical Center — Boise, Idaho (18.1 mi)
· Sponsor: Ferring Pharmaceuticals
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Boise — Meridian, Idaho (8.8 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
HPV, HPV - Anogenital Human Papilloma Virus Infection
N/A
Interventional 260 participants sought
ASR Idaho CGI — Boise, Idaho (18.1 mi)
· Sponsor: Mel Mont Medical
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
St. Luke's Idaho Cardiology Associates — Meridian, Idaho (8.8 mi)
· Sponsor: Novo Nordisk A/S
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Saint Alphonsus Regional Medical Center ( Site 0067) — Boise, Idaho (18.1 mi)
· Sponsor: Merck Sharp & Dohme LLC